ClinicalTrials.Veeva

Menu

Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Intensive Care

Study type

Observational

Funder types

Other

Identifiers

NCT02924844
IRB 14/05.03

Details and patient eligibility

About

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Enrollment

2,787 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Intensive Care Unit patients on weekdays

Trial design

2,787 participants in 2 patient groups

Observation period before presence of clinical pharmacist
Description:
The group of patients was observed between Janary 2013 and December 2013
Period with presence of clinical pharmacist
Description:
The group of patients was observed between January 2014 and June 2015.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems